Cost-effectiveness of prophylactic indomethacin in very-low-birth-weight infants.

Moya, Martin P; Goldberg, Ronald N

Moya, Martin P; Goldberg, Ronald N.

Affiliation

Moya MP; Department of Pediatrics, Division of Neonatology, Duke University Medical Center, Durham, NC, USA. mmoya@vitametrix.com

Ann Pharmacother ; 36(2): 218-24, 2002 Feb.

Article in En | MEDLINE | ID: mdl-11847937

Subject(s)

Anti-Inflammatory Agents, Non-Steroidal/economics; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use; Indomethacin/economics; Indomethacin/therapeutic use; Infant, Very Low Birth Weight; Cerebral Hemorrhage/economics; Cerebral Hemorrhage/prevention & control; Cohort Studies; Cost-Benefit Analysis; Decision Trees; Ductus Arteriosus, Patent/economics; Ductus Arteriosus, Patent/prevention & control; Humans; Infant, Newborn; MEDLINE; Randomized Controlled Trials as Topic; Retrospective Studies; Sensitivity and Specificity

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Anti-Inflammatory Agents, Non-Steroidal / Indomethacin / Infant, Very Low Birth Weight Type of study: Diagnostic_studies / Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Humans / Newborn Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2002 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links